Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2026-05-18 @ 4:04 PM
Study NCT ID:
NCT02134834
Status:
COMPLETED
Last Update Posted:
2014-12-12
First Post:
2014-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595
Sponsor:
Meiji Seika Pharma Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OP0595-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None